McCormack, Meredith
Paczkowski, Rosirene
Gronroos, Noelle N. http://orcid.org/0009-0000-0624-1022
Noorduyn, Stephen G. http://orcid.org/0000-0002-5936-5579
Lee, Lydia http://orcid.org/0000-0002-8114-6508
Veeranki, Phani http://orcid.org/0000-0002-8645-1990
Johnson, Mary G.
Igboekwe, Emmeline
Kahle-Wrobleski, Kristin
Panettieri, Reynold
Funding for this research was provided by:
GSK
Article History
Received: 28 September 2023
Accepted: 18 December 2023
First Online: 4 February 2024
Declarations
:
: Meredith McCormack has received consulting fees from Aridis Pharmaceuticals, GSK, Boehringer Ingelheim, and MCG Diagnostics and has received royalties for authorship from UpToDate. Meredith McCormack has also served on the medical advisory board for ndd Technology. Rosirene Paczkowski, Stephen G. Noorduyn, Emmeline Igboekwe, and Kristin Kahle-Wrobleski are employees of, and/or hold stocks/shares, in GSK. Lydia Lee is a university worker hired by GSK. Noelle N. Gronroos, Phani Veeranki, and Mary G. Johnson are employees of, and hold stocks/shares in, Optum, which received funding from GSK to conduct this study. Reynold Panettieri has received research grants from AZ, RIFM, TEVA, MedImmune, and AgoMab and has featured on advertisement boards for AZ, RIFM Genentech, and Praesidia. Reynold Panettieri has also worked as a speaker for AZ, Sanofi, and Merck.
: This study complied with all applicable laws regarding subject privacy, no subject identifiers are included in these results, and no direct subject contact or primary collection of individual human subject data took place. All study results are in tabular form and are presented as aggregate analyses that omit subject identification; therefore, informed consent and ethics committee or institutional review board approval were not required.